Individuals' willingness to talk to their doctors about clinical trial enrollment

Journal of Health Communication

Volumn 15, Issue 2, 2010, Pages 189-204

  McComas, Katherine A ^a   Yang, Zheng ^b   Gay, Geri K ^a   Leonard, John P ^c   Dannenberg, Andrew J ^c   Dillon, Hildy ^d  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Leukemia Lymphoma Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; DOCTOR PATIENT RELATION; HUMAN; PATIENT SELECTION; QUESTIONNAIRE; TELEPHONE; TRUST;

ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT SELECTION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; TELEPHONE; TRUST;

EID: 77949530174     PISSN: 10810730     EISSN: 10870415     Source Type: Journal    
DOI: 10.1080/10810730903528058     Document Type: Article

References (63)

1. Abraham, N. S., Young, J. M., &Solomon, M. J. (2006). A systematic review of reasons for nonentry of eligible patients into surgical randomized controlled trials. Surgery, 139(4), 469-483.
2. Albrecht, T. L., Blanchard, C., Ruckdeschel, J. C., Coovert, M., &Strongbow, R. (1999). Strategic physician communication and oncology clinical trials. Journal of Clinical Oncology, 17(10), 3324-3332.
3. Albrecht, T. L., Ruckdeschel, J. C., Riddle, D. L., Blanchard, C. G., Penner, L. A., Coovert, M. D., et al. (2003). Communication and consumer decision making about cancer clinical trials. Patient Education and Counseling, 50(1), 39-42.
4. Ajzen, I. (1988). Attitudes, personality, and behavior. Milton Keynes, UK: Open University Press.
5. The American Association for Public Opinion Research (AAPOR). (2008). Standard definitions: Final dispositions of case codes and outcome rates for surveys (5th ed.). Lenexa, KS: Author.
6. Baquet, C. R., Commiskey, P., Mullins, C. D., &Mishra, S. I. (2006). Recruitment and participation in clinical trials: Socio-demographic, rural=urban, and health care access predictors. Cancer Detection and Prevention, 30(1), 24-33.
7. Bies, R. J. (2005). Are procedural justice and interactional justice conceptually distinct? In J. Greenberg &J. A. Colquitt (Eds.), Handbook of organizational justice (pp. 85-112). Mahwah, NJ: Erlbaum.
8. Bies, R. J., &Moag, J. F. (1986). Interactional justice: Communication criteria of fairness. In R. J. Lewicki, B. H. Sheppard, &M. H. Bazerman (Eds.), Research on negotiations in organizations (vol. 1, pp. 43-55). Greenwich, CT: JAI Press.
9. Brown, R. F., Butow, P. N., Ellis, P., Boyle, F., &Tattersall, M. H. N. (2004). Seeking informed consent to cancer clinical trials: Describing current practice. Social Science &Medicine, 58(12), 2445-2457.
10. Castel, P., Negrier, S., &Boissel, J. P. (2006). Why don't cancer patients enter clinical trials? A review. European Journal of Cancer, 42(12), 1744-1748.
11. Charles, C., Gafni, A., &Whelan, T. (1999). Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Social Science &Medicine, 49(5), 651-661.
12. Cohen, J., Cohen, P., West, S. G., &Aiken, L. S. (2003). Applied multiple regression=correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ: Erlbaum Associates.
13. Colquitt, J. A., Conlon, D. E., Wesson, M. J., Porter, C., &Ng, K. Y. (2001). Justice at the millennium: A meta-analytic review of 25 years of organizational justice research. Journal of Applied Psychology, 86(3), 425-445.
14. Colquitt, J. A., Greenberg, J., &Zapata-Phelan, C. P. (2005). What is organizational justice? A historical overview. In J. Greenberg &J. A. Colquitt (Eds.), Handbook of organizational justice (pp. 3-56). Mahwah, NJ: Erlbaum.
15. Comis, R. L., Miller, J. D., Aldige, C. R., Krebs, L., &Stoval, E. (2003). Public attitudes toward participation in cancer clinical trials. Journal of Clinical Oncology, 21(5), 830-835.
16. Curbow, B., Fogarty, I. A., McDonnell, K. A., Chill, J., &Scott, I. B. (2006). The role of physician characteristics in clinical trial acceptance: Testing pathways of influence. Journal of Health Communication, 11(2), 199-218.
17. Du Toit, B. M. (1980). Ethics, informed consent, and fieldwork. Journal of Anthropological Research, 36(3), 274-286.
18. Fallowfield, L. J., Jenkins, V., Brennan, C., Sawtell, M., Moynihan, C., &Souhami, R. L. (1998). Attitudes of patients to randomised clinical trials of cancer therapy. European Journal of Cancer, 34(10), 1554-1559.
19. Fallowfield, L., Ratcliffe, D., &Souhami, R. (1997). Clinicians' attitudes to clinical trials of cancer therapy. European Journal of Cancer, 33(13), 2221-2229.
20. Giuliano, A. R., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R. C. S., et al. (2000). Participation of minorities in cancer research: The influence of structural, cultural, and linguistic factors. Annals of Epidemiology, 10(8), S22-S34.
21. Grady, C., Hampson, L. A., Wallen, G. R., Rivera-Goba, M. V., Carrington, K. L., &Mittleman, B. B. (2006). Exploring the ethics of clinical research in an urban community. American Journal of Public Health, 96(11), 1996-2001.
22. Grant, C. H., Cissna, K. N., &Rosenfeld, L. B. (2000). Patients' perceptions of physicians' communication and outcomes of the accrual to trial process. Health Communication, 12(1), 23-39.
23. Gray, B. H., Cooke, R. A., &Tannenbaum, S. S. (1978). Research involving human subjects. Science, 201, 1094-1101.
24. Greenberg, J. (1993). The social side of fairness: Interpersonal and informational classes of organizational justice. In R. Cropanzano (Ed.), Justice in the workplace: Approaching fairness in human resource management (pp. 79-103). Hillsdale, NJ: Erlbaum.
25. Harris, Y., Gorelick, P. B., Samuels, P., &Bempong, I. (1996). Why African Americans may not be participating in clinical trials. Journal of the National Medical Association, 88(10), 630-634.
26. Hutchison, C., &Campbell, S. (2002). Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer. European Journal of Cancer Care, 11(2), 131-138.
27. Jenkins, V., &Fallowfield, L. (2000). Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy. British Journal of Cancer, 82(11), 1783-1788.
28. Jenkins, V. A., Fallowfield, L. J., Souhami, A., &Sawtell, M. (1999). How do doctors explain randomised clinical trials to their patients? European Journal of Cancer, 35(8), 1187-1193.
29. Kodish, E., Eder, M., Noll, R. B., Ruccione, K., Lange, B., Angiolillo, A., et al. (2004). Communication of randomization in childhood leukemia trials. Jama-Journal of the American Medical Association, 291(4), 470-475.
30. Lee, J. Y., &Breaux, S. R. (1983). Accrual of radiotherapy patients to clinical trials. Cancer, 52, 1014-1016.
31. Lind, E. A., &Tyler, T. R. (1988). The social psychology of procedural justice. New York: Plenum Press.
32. Madsen, S. M., Mirza, M. R., Holm, S., Hilsted, K. L., Kampmann, K., &Riis, P. (2002). Attitudes towards clinical research amongst participants and nonparticipants. Journal of Internal Medicine, 251(2), 156-168.
33. Mannel, R. S., Walker, J. L., Gould, N., Scribner, D. R., Kamelle, S., Tillmanns, T., et al. (2003). Impact of individual physicians on enrollment of patients into clinical trials. American Journal of Clinical Oncology-Cancer Clinical Trials, 26(2), 171-173.
34. McComas, K. A., Besley, J. C., &Yang, Z. (2008). Risky business: Perceived behavior of local scientists and community support for their research. Risk Analysis, 28, 1539-1552.
35. McComas, K., Trumbo, C., &Besley, J. (2007). Public meetings about suspected cancer clusters: The impact of voice, interactional justice, and risk perception on attendees' attitudes in six communities. Journal of Health Communication, 12, 527-549.
36. McFarlin, D. B., &Sweeney, P. D. (1992). Distributive and procedural justice as predictors of satisfaction with personal and organizational outcomes. The Academy of Management Journal, 35, 626-637.
37. Mills, E. J., Seely, D., Rachlis, B., Griffith, L., Wu, P., Wilson, K., et al. (2006). Barriers to participation in clinical trials of cancer: A meta-analysis and systematic review of patient-reported factors. Lancet Oncology, 7(2), 141-148.
38. Mills, E., Wilson, K., Rachlis, B., Griffith, L., Wu, P., Guyatt, G., et al. (2006). Barriers to participation in HIV drug trials: A systematic review. Lancet Infectious Diseases, 6(1), 32-38.
39. National Cancer Institute. (2006, February 28). Boosting cancer trial participation. Retrieved January 12, 2007, from http://www.cancer.gov/ clinicaltrials/digestpage/boosting-trialparticipation
40. Nievaard, M. A. F., De Vos, R., De Haes, J., &Levi, M. (2004). Reasons why patients do or do not participate in clinical trials: A systematic review of the literature. Nederlands Tijdschrift Voor Geneeskunde, 148(4), 186-190.
41. Paulhus, D. L., Robins, R. W., Trzesniewski, K. H., &Tracy, J. L. (2004). Two replicable suppressor situations in personality research. Multivariate Behavioral Research, 39(2), 303-328.
42. Penman, D. T., Holland, J. C., Bahna, G. F., Morrow, G., Schmale, A. H., Derogatis, L. R., Camrike, C. L., Jr., &Cherry, R. (1984). Informed consent for investigational chemotherapy: Patients' and physicians' perceptions. Journal of Clinical Oncology, 2, 849-855.
43. Preacher, K. J., &Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods, Instruments, &Computers, 36(4), 717-731.
44. Rosenberg, M. (1968). The logic of survey analysis. New York: Basic Books, Inc.
45. Sankar, P. (2004). Communication and miscommunication in informed consent to research. Medical Anthropology Quarterly, 18(4), 429-446.
46. Sawka, C. A., &Pritchard, K. I. (2001). Can improved communication increase patient participation in randomised clinical trials? European Journal of Cancer, 37(3), 297-299.
47. Sharp, L., Cotton, S. C., Alexander, L., Williams, E., Gray, N. M., &Reid, J. M. (2006). Reasons for participation and non-participation in a randomized controlled trial: Postal questionnaire surveys of women eligible for tombola (trial of management of borderline and other low-grade abnormal smears). Clinical Trials, 3(5), 431-442.
48. Simon, M. S., Du, W., Flaherty, L., Philip, P. A., Lorusso, P., Miree, C., et al. (2004). Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. Journal of Clinical Oncology, 22(11), 2046-2052.
49. Somkin, C. P., Altschuler, A., Ackerson, L., Geiger, A. M., Greene, S. M., Mouchawar, J., et al. (2005). Organizational barriers to physician participation in cancer clinical trials. American Journal of Managed Care, 11(7), 413-421.
50. Stryker, J. E., Wray, R. J., Emmons, K. M., Winer, E., &Demetri, G. (2006). Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret. Patient Education and Counseling, 63(1-2), 104-109.
51. Thibaut, J. W., &Walker, L. (1975). Procedural justice: A psychological analysis. Mahwah, NJ: Lawrence Erlbaum Associates.
52. Tyler, T. R. (1989). The psychology of procedural justice-A test of the group-value model. Journal of Personality and Social Psychology, 57(5), 830-838.
53. Tyler, T. R. (1994). Psychological models of the justice motive: Antecedents of distributive and procedural justice. Journal of Personality and Social Psychology, 67, 850-863.
54. Tyler, T. R. (2000). Social justice: Outcome and procedure. International Journal of Psychology, 35(2), 117-125.
55. Tyler, T. R., Degoey, P., &Smith, H. J. (1996). Understanding why the justice of group procedures matters: A test of the psychological dynamics of the group-value model. Journal of Personality and Social Psychology, 70(5), 913-930.
56. Tyler, T. R., &Folger, R. (1980). Distributional and procedural aspects of satisfaction with citizen-police encounters. Basic and Applied Social Psychology, 4, 281-292.
57. Tyler, T. R., &Lind, E. A. (1992). A relational model of authority in groups. Advances in Experimental Social Psychology, 25, 115-191.
58. van den Bos, K. (2001). Uncertainty management: The influence of uncertainty salience on reactions to perceived procedural fairness. Journal of Personality and Social Psychology, 80(6), 931-941.
59. van den Bos, K. (2005). What is responsible for the fair process effect? In J. Greenberg &J. A. Colquitt (Eds.), Handbook of organizational justice (pp. 273-300). Mahwah, NJ: Lawrence Erlbaum Associates.
60. van den Bos, K., &Lind, E. A. (2002). Uncertainty management by means of fairness judgments. In M. P. Zanna (Ed.), Advances in experimental social psychology (Vol. 34, pp. 1-60). San Diego, CA: Academic Press.
61. van den Bos, K., Wilke, H. A. M., &Lind, E. A. (1998). When do we need procedural fairness? The role of trust in authority. Journal of Personality and Social Psychology, 75(6), 1449-1458.
62. Veatch, R. M. (1995). Abandoning informed consent. Hastings Center Report, 25(2), 5-12.
63. Wright, J. R., Whelan, T. J., Schiff, S., Dubois, S., Crooks, D., Haines, P. T., et al. (2004). Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decision. Journal of Clinical Oncology, 22(21), 4312-4318.